asthma - Nursing Case Study
Pathophysiology
• Primary mechanism: In asthma, airway inflammation is a central feature, characterized by the infiltration of inflammatory cells like eosinophils and T-lymphocytes, leading to swelling and increased mucus production, which narrows the airways and obstructs airflow.
• Secondary mechanism: Bronchial hyperresponsiveness occurs due to the inflamed airways, where they become overly sensitive to various stimuli such as allergens or irritants, causing them to constrict excessively and further reduce airflow.
• Key complication: This combination of inflammation and hyperresponsiveness can lead to acute asthma exacerbations, characterized by severe shortness of breath and wheezing, which require prompt medical intervention to prevent respiratory distress.
Patient Profile
Demographics:
45-year-old female, office manager
History:
• Key past medical history: Asthma diagnosed 10 years ago, seasonal allergic rhinitis
• Current medications: Inhaled corticosteroid (Fluticasone), Albuterol inhaler as needed, Montelukast
• Allergies: Penicillin, dust mites
Current Presentation:
• Chief complaint: Worsening shortness of breath and persistent cough
• Key symptoms: Wheezing, chest tightness, increased nocturnal awakenings due to breathing difficulties, fatigue
• Vital signs: Blood pressure 140/90 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 90% on room air, temperature 37.5°C (99.5°F)
Section 1
As the clinical team assesses the patient, several concerning findings emerge. The patient's respiratory status continues to deteriorate, with her oxygen saturation dropping to 88% despite the administration of supplemental oxygen via nasal cannula at 2 liters per minute. Auscultation reveals diffuse wheezing throughout all lung fields, with diminished breath sounds particularly in the lower lobes, suggesting possible mucus plugging or atelectasis. The patient's heart rate remains elevated at 115 bpm, and her blood pressure has risen slightly to 145/92 mmHg, indicating a possible stress response to hypoxia and respiratory distress. The patient's respiratory rate has increased to 28 breaths per minute, with noticeable use of accessory muscles, reflecting her increased work of breathing.
Laboratory tests and diagnostic imaging are promptly ordered to gain further insight into the patient's condition. An arterial blood gas (ABG) analysis reveals a pH of 7.34, PaCO2 of 48 mmHg, and PaO2 of 58 mmHg, indicating respiratory acidosis and hypoxemia. A chest X-ray is obtained, which shows hyperinflated lungs with peribronchial thickening but no evidence of pneumonia or significant collapse. Blood tests indicate an elevated eosinophil count, supporting the diagnosis of an exacerbation driven by inflammation.
In light of these findings, the medical team initiates a more aggressive treatment plan. The patient is administered a nebulized bronchodilator treatment and intravenous corticosteroids to rapidly reduce airway inflammation. Magnesium sulfate is considered as an adjunct therapy given her severe presentation. The team discusses the possibility of admission to the hospital for closer monitoring and more intensive treatment, given the risk of further complications such as respiratory failure. These steps are crucial to stabilize the patient and prevent the progression of her asthma exacerbation, emphasizing the importance of timely and effective intervention in managing moderate asthma complications.
Section 2
As the medical team continues to monitor the patient closely, they note a change in her status that requires immediate attention. Despite the administration of nebulized bronchodilators and intravenous corticosteroids, the patient's respiratory distress persists, and her oxygen saturation remains stubbornly low, hovering around 86% on 2 liters per minute of oxygen. Recognizing the need for enhanced respiratory support, the team decides to escalate the oxygen delivery method, switching to a high-flow nasal cannula at 40 liters per minute with an FiO2 of 0.5. This adjustment aims to improve her oxygenation and alleviate some of the work of breathing by providing adequate flow and pressure support.
In parallel, the patient's clinical presentation prompts a re-evaluation of her treatment plan. Her heart rate has decreased slightly to 105 bpm, but she continues to display profound fatigue and increased accessory muscle use, indicating that her respiratory muscles are becoming fatigued from prolonged effort. Additionally, her arterial blood gas analysis reveals a persistent respiratory acidosis, with a pH now at 7.32 and a PaCO2 of 50 mmHg, signaling inadequate ventilation. Recognizing the potential for respiratory failure, the team considers the need for non-invasive ventilation or, if necessary, intubation to support her breathing further.
As these developments unfold, the team also notes the emergence of a new complication: the patient’s blood pressure has increased further to 158/96 mmHg, potentially exacerbated by the corticosteroid treatment and the physiological stress of her condition. This hypertension requires careful monitoring and potentially the introduction of antihypertensive therapy if it does not resolve with improved respiratory status. The medical team remains vigilant, aware that the next steps in her care will be critical in preventing further deterioration and ensuring a positive outcome.
Section 3
As the medical team continues to closely monitor the patient, they observe a significant change in her clinical status. Despite the adjustment to high-flow nasal cannula therapy, the patient's respiratory distress remains pronounced, and her oxygen saturation has only marginally improved to 88%. Her respiratory rate has increased to 34 breaths per minute, indicating continued respiratory effort and possible progression towards respiratory failure. Alarmingly, the patient's level of consciousness begins to alter; she becomes increasingly lethargic and less responsive to verbal stimuli. This change raises immediate concern for hypoxic encephalopathy, prompting the team to reassess her overall neurological status and consider the implications of prolonged hypoxemia.
In response to these developments, the medical team orders a repeat arterial blood gas analysis to evaluate her current respiratory and metabolic state. The results reveal a worsening respiratory acidosis, with the pH now at 7.28 and PaCO2 elevated to 54 mmHg, indicating further deterioration in her ventilatory function. Concurrently, the chest X-ray is re-evaluated and shows slight hyperinflation but no signs of pneumothorax or pneumonia, ruling out additional pulmonary complications. These findings suggest that despite maximal medical therapy, the patient is failing to adequately ventilate, and her condition may necessitate more aggressive respiratory support.
Given the critical nature of these findings, the medical team discusses the possibility of transitioning to non-invasive positive pressure ventilation (NIPPV) to provide increased ventilatory assistance. They weigh the benefits of NIPPV in reducing the work of breathing and improving gas exchange against the potential need for intubation should her mental status continue to decline. Furthermore, the team remains vigilant for any new complications, such as the risk of barotrauma or aspiration, while also considering the management of her hypertension, which remains elevated. The decisions made at this juncture will be pivotal in stabilizing the patient and preventing further respiratory compromise.
Section 4
As the medical team proceeds with initiating non-invasive positive pressure ventilation (NIPPV), they monitor the patient's response closely. Initially, there is a noteworthy improvement in her oxygen saturation, which rises to 92%, and her respiratory rate decreases to 28 breaths per minute, suggesting a reduction in her work of breathing. However, the team observes that while her oxygenation parameters have improved slightly, her level of consciousness remains concerning. The patient continues to exhibit lethargy and is now intermittently disoriented, which prompts the team to conduct a thorough neurological assessment, evaluating her Glasgow Coma Scale (GCS) score. Her GCS score has decreased to 10, indicating moderate impairment and necessitating immediate action to prevent further neurological compromise.
In light of her persistent altered mental status, the team decides to perform an urgent CT scan of the brain to rule out any acute intracranial pathology that could be contributing to her neurological symptoms. The scan reveals no evidence of hemorrhage or infarction, thereby confirming that hypoxic encephalopathy remains the most likely cause of her altered consciousness. Concurrently, a repeat blood gas analysis shows a slight improvement in her acidosis, with the pH now at 7.32 and PaCO2 reduced to 48 mmHg, reflecting partial respiratory compensation but underscoring the need for ongoing respiratory support.
The medical team also reassesses her cardiovascular status, noting that her blood pressure continues to be elevated at 160/95 mmHg, which may exacerbate her cerebral hypoxia. They adjust her antihypertensive regimen to better control her blood pressure, while also optimizing her fluid balance to avoid fluid overload. With these interventions, the team aims to stabilize her condition further, hoping to improve her neurological status over time. The possibility of progression to invasive mechanical ventilation remains under consideration, should her respiratory or neurological status fail to improve adequately with NIPPV. The team remains vigilant for further complications, such as ventilator-associated lung injury or hemodynamic instability, as they continue to navigate the complexities of her care.
Section 5
As the medical team continues to monitor the patient closely, they observe a change in her status that necessitates further evaluation. Despite initial improvements in her respiratory parameters with NIPPV, the patient's respiratory rate begins to increase again, now reaching 34 breaths per minute, and her oxygen saturation starts to fall back to 88%, indicating a potential decline in her respiratory function. Her increased work of breathing is evident from the use of accessory muscles and nasal flaring, suggesting that the current level of NIPPV may no longer be sufficient to meet her respiratory demands.
In response to these changes, the team performs another arterial blood gas analysis, which now reveals a pH of 7.28 and a PaCO2 of 52 mmHg, indicating a worsening respiratory acidosis. Concurrently, her lactate level has risen to 3.5 mmol/L, possibly reflecting increased anaerobic metabolism due to inadequate oxygenation. The combination of these findings raises concerns about the adequacy of her current respiratory support and the risk of further deterioration.
Given the patient's declining respiratory status and persistent altered mental status, the medical team convenes to reassess their management strategy. They recognize that while NIPPV has provided temporary support, the patient's worsening respiratory acidosis and hypoxia necessitate a more aggressive intervention. After a thorough discussion, the decision is made to proceed with intubation and transition to invasive mechanical ventilation to ensure adequate ventilation and oxygenation. This decision is made in conjunction with continued monitoring for potential complications such as barotrauma or ventilator-associated pneumonia, as the team remains committed to optimizing the patient's care and preventing further clinical decline.